Final results of RENO study: Randomized phase II of oral vinorelbine or etoposide with cisplatin & chemo-radiation in stage III NSCLC - SLCG 10/02

Autor:	P. Mut Sanchis, M.A. Sala Gonzalez, M.D. Isla Casado, José Miguel Jurado, V. Gutierrez Calderon, A. Insa Molla, B. Massuti Sureda, I. Maestu Maiques, J. Gomez Codina, R. Marse Fabregat, N. Martinez Banaclocha, M. Provencio Pulla, R. de las Peñas, Carlos Camps, Thomas M. Moran, A.L. Ortega Granados, P. Diz Tain, Felipe Vazquez, Angel Artal-Cortes, N. Vinolas Segarra
Rok vydání:	2018
Předmět:	Cisplatin Oncology medicine.medical_specialty business.industry Stage III NSCLC Hematology Vinorelbine Chemo radiation Internal medicine medicine business Etoposide medicine.drug
Zdroj:	Annals of Oncology. 29:viii490
ISSN:	0923-7534
DOI:	10.1093/annonc/mdy291.008
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::602e9e12799acd0952a54cae24f8b646 https://doi.org/10.1093/annonc/mdy291.008 Zobrazit plný text záznamu